Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma
Principal Investigator: Praveen Sethupathy
Department of Biomedical Sciences
Email:
pr46@cornell.edu
Sponsor:
Alnylam Pharmaceuticals Inc.
Title:
Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma
Project Amount:
$55,407
Project Period:
December 2021
to
December 2022